Publikationen

An dieser Stelle finden Sie ausgewählte Publikationen zur Strahlentherapie:

Djuzenova CS, Fiedler V, Memmel S, Katzer A, Hartmann S, Krohne G, Zimmermann H, Scholz CJ, Polat B, Flentje M, Sukhorukov VL. (2015) Actin cytoskeleton organization, cell surface modification and invasion rate of 5 glioblastoma cell lines differing in PTEN and p53 status. Exp Cell Res 330:346-357.

Holubyev K, Gainey M, Bratengeier K, Polat , Flentje M. (2014) Generation of prostate IMAT plans adaptable to the inter-fractional changes of patient geometry. Phys Med Biol 59:1947-62.

Guckenberger M, Klement RJ, Allgäuer et al. (2015) Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy. Radiother Oncol j.radonc.2015.09.008. [Epub ahead of print].

Jaenicke LA, von Eyss B, Carstensen A, Wolf E, Xu W, Greifenberg AK, Geyer M, Eilers M, Popov N. (2015) Ubiquitin-Dependent Turnover of MYC Antagonizes MYC/PAF1C Complex Accumulation to Drive Transcriptional Elongation. Mol Cell j.molcel.2015.11.007. Epub 2015 Dec 10.

Thomas L, Lapa C, Bundschuh RA, Polat B, Sonke JJ, Guckenberger M. (2015) Tumour delineation in oesophageal cancer - A prospective study of delineation in PET and CT with and without endoscopically placed clip markers. Radiother Oncol 116:269-75.

Publikationen 2016

Alt-Epping B, Seidel W, Vogt J, Mehnert A, Thomas M, van Oorschot B, Wolff H, Schliephake H, Canis M, Dröge LH, Nauck F, Lordick F, Arbeitsgemeinschaft Palliativmedizin (APM) of the German Cancer Society (DKG). (2016) Symptoms and Needs of Head and Neck Cancer Patients at Diagnosis of Incurability - Prevalences, Clinical Implications, and Feasibility of a Prospective Longitudinal Multicenter Cohort Study. Oncol Res Treat 39(4):186-91.

Berendt J, Oechsle K, Thomas M, van Oorschot B, Schmitz A, Radbruch L, Simon ST, Gärtner J, Thuß-Patience P, Schuler US, Hense J, Gog C, Viehrig M, Mayer-Steinacker R, Stachura P, Stiel S, Ostgathe C. (2016) State of integration of palliative care at Comprehensive Cancer Centers funded by German Cancer Aid. Dtsch Med Wochenschr 141(2):e16-23.

Bluemel C, Krebs M, Polat B, Linke F, Eiber M, Samnick S, Lapa C, Lassmann M, Riedmiller H, Czernin J, Rubello D, Bley T, Kropf S, Wester HJ, Buck AK, Herrmann K. (2016) 68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CT. Clin Nucl Med 41(7):515-21.

Bratengeier K, Holubyev K. (2016) Anisotropy of dose contributions-An instrument to upgrade real time IMRT and VMAT adaptation? Med Phys 43(11):5826.

Colvill E, Booth J, Nill S, Fast M, Bedford J, Oelfke U, Nakamura M, Poulsen P, Worm E, Hansen R, Ravkilde T, Scherman Rydhög J, Pommer T, Munck Af Rosenschold P, Lang S, Guckenberger M, Groh C, Herrmann C, Verellen D, Poels K, Wang L, Hadsell M, Sothmann T, Blanck O, Keall P. (2016) A dosimetric comparison of real-time adaptive and non-adaptive radiotherapy: A multi-institutional study encompassing robotic, gimbaled, multileaf collimator and couch tracking. Radiother Oncol 119(1):159-65.   

Djuzenova CS, Fiedler V, Katzer A, Michel K, Deckert S, Zimmermann H, Sukhorukov VL, Flentje M. (2016) Dual PI3K- and mTOR-inhibitor PI-103 can either enhance or reduce the radiosensitizing effect of the Hsp90 inhibitor NVP-AUY922 in tumor cells: The role of drug-irradiation schedule. Oncotarget 7(25):38191-38209.

Flentje M, Huber RM, Engel-Riedel W, Andreas S, Kollmeier J, Staar S, Dickgreber N, Vaissiere N, De Almeida C, Edlich B, Fietkau R. (2016) GILT--A randomised phase III study of oral vinorelbine and cisplatin with concomitant radiotherapy followed by either consolidation therapy with oral vinorelbine and cisplatin or best supportive care alone in stage III non-small cell lung cancer. Strahlenther Onkol 192(4):216-22.

Guckenberger M, Klement RJ, Allgäuer M, Andratschke N, Blanck O, Boda-Heggemann J, Dieckmann K, Duma M, Ernst I, Ganswindt U, Hass P, Henkenberens C, Holy R, Imhoff D, Kahl HK, Krempien R, Lohaus F, Nestle U, Nevinny-Stickel M, Petersen C, Semrau S, Streblow J, Wendt TG, Wittig A, Flentje M, Sterzing F. (2016) Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy. Radiother Oncol 118(3):485-91.

Hashmi A, Guckenberger M, Kersh R, Gerszten PC, Mantel F, Grills IS, Flickinger JC, Shin JH, Fahim DK, Winey B, Oh K, John Cho BC, Létourneau D, Sheehan J, Sahgal A. (2016) Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis. J Neurosurg Spine 25(5):646-653.

Jawad MS, Fahim DK, Gerszten PC, Flickinger JC, Sahgal A, Grills IS, Sheehan J, Kersh R, Shin J, Oh K, Mantel F, Guckenberger M, on behalf of the Elekta Spine Radiosurgery Research Consortium. (2016) Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation. J Neurosurg Spine 24(6):928-36.

Klement RJ, Allgäuer M, Andratschke N, Blanck O, Boda-Heggemann J, Dieckmann K, Duma M, Ernst I, Flentje M, Ganswindt U, Hass P, Henkenberens C, Imhoff D, Kahl HK, Krempien R, Lohaus F, Nestle U, Nevinny-Stickel M, Petersen C, Schmitt V, Semrau S, Sterzing F, Streblow J, Wendt TG, Wittig A, Guckenberger M. (2016) Bayesian Cure Rate Modeling of Local Tumor Control: Evaluation in Stereotactic Body Radiation Therapy for Pulmonary Metastases. Int J Radiat Oncol Biol Phys 94(4):841-9.

Klement RJ, Belderbos J, Grills I, Werner-Wasik M, Hope A, Giuliani M, Ye H, Sonke JJ, Peulen H, Guckenberger M. (2016) Prediction of Early Death in Patients with Early-Stage NSCLC-Can We Select Patients without a Potential Benefit of SBRT as a Curative Treatment Approach? J Thorac Oncol 11(7):1132-9.

Li M, Dick A, Hassold N, Pabst T, Bley T, Köstler H, Neubauer H. (2016) CAIPIRINHA-accelerated T1w 3D-FLASH for small-bowel MR imaging in pediatric patients with Crohn's disease: assessment of image quality and diagnostic performance. World J Pediatr 12(4):455-462.

Ott OJ, Strnad V, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, ?yczek J, Guinot JL, Dunst J, Miguelez CG, Slampa P, Allgäuer M, Lössl K, Polat B, Kovács G, Fischedick AR, Wendt TG, Fietkau R, Kortmann RD, Resch A, Kulik A, Arribas L, Niehoff P, Guedea F, Schlamann A, Pötter R, Gall C, Malzer M, Uter W, Polgár C, Groupe Européen de Curiethérapie of European Society for Radiotherapy and Oncology (GEC-ESTRO). (2016) GEC-ESTRO multicenter phase 3-trial: Accelerated partial breast irradiation with interstitial multicatheter brachytherapy versus external beam whole breast irradiation: Early toxicity and patient compliance. Radiother Oncol 120(1):119-23.

"Peulen H, Mantel F, Guckenberger M, Belderbos J, Werner-Wasik M, Hope A, Giuliani M, Grills I, Sonke JJ. (2016) Validation of High-Risk Computed Tomography Features for Detection of Local Recurrence After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 96(1):134-41.

Rades D, ?egedin B, Conde-Moreno AJ, Garcia R, Perpar A, Metz M, Badakhshi H, Schreiber A, Nitsche M, Hipp P, Schulze W, Adamietz IA, Norkus D, Rudat V, Cacicedo J, Schild SE. (2016) Radiotherapy With 4 Gy × 5 Versus 3 Gy × 10 for Metastatic Epidural Spinal Cord Compression: Final Results of the SCORE-2 Trial (ARO 2009/01). J Clin Oncol 34(6):597-602.

Richter A, Polat B, Lawrenz I, Weick S, Sauer O, Flentje M, Mantel F. (2016) Initial results for patient setup verification using transperineal ultrasound and cone beam CT in external beam radiation therapy of prostate cancer. Radiat Oncol 11(1):147.

Rieber J, Streblow J, Uhlmann L, Flentje M, Duma M, Ernst I, Blanck O, Wittig A, Boda-Heggemann J, Krempien R, Lohaus F, Klass ND, Eble MJ, Imhoff D, Kahl H, Petersen C, Gerum S, Henkenberens C, Adebahr S, Hass P, Schrade E, Wendt TG, Hildebrandt G, Andratschke N, Sterzing F, Guckenberger M. (2016) Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy". Lung Cancer 97:51-8.

"Roesch J, Panje C, Sterzing F, Mantel F, Nestle U, Andratschke N, Guckenberger M. (2016) SBRT for centrally localized NSCLC - What is too central? Radiat Oncol 11(1):157.

Strnad V, Ott OJ, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, Lyczek J, Guinot JL, Dunst J, Gutierrez Miguelez C, Slampa P, Allgäuer M, Lössl K, Polat B, Kovács G, Fischedick AR, Wendt TG, Fietkau R, Hindemith M, Resch A, Kulik A, Arribas L, Niehoff P, Guedea F, Schlamann A, Pötter R, Gall C, Malzer M, Uter W, Polgár C, Groupe Européen de Curiethérapie of European Society for Radiotherapy and Oncology (GEC-ESTRO) (2016) 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a ran. Lancet 387(10015):229-38.    

Toussaint A, Richter A, Mantel F, Flickinger JC, Grills IS, Tyagi N, Sahgal A, Letourneau D, Sheehan JP, Schlesinger DJ, Gerszten PC, Guckenberger M. (2016) Variability in spine radiosurgery treatment planning - results of an international multi-institutional study. Radiat Oncol 11:57.

Xu W, Taranets L, Popov N. (2016) Regulating Fbw7 on the road to cancer. Semin Cancer Biol 36:62-70.

Publikationen 2015

Bratengeier K, Holubyev K. (2015) Characteristics of non-coplanar IMRT in the presence of target-embedded organs at risk. Radiat Oncol 10:207.

Djuzenova CS, Fiedler V, Memmel S, Katzer A, Hartmann S, Krohne G, Zimmermann H, Scholz CJ, Polat B, Flentje M, Sukhorukov VL. (2015) Actin cytoskeleton organization, cell surface modification and invasion rate of 5 glioblastoma cell lines differing in PTEN and p53 status. Exp Cell Res 330(2):346-57.

Djuzenova CS, Zimmermann M, Katzer A, Fiedler V, Distel LV, Gasser M, Waaga-Gasser AM, Flentje M, Polat B. (2015) A prospective study on histone ?-H2AX and 53BP1 foci expression in rectal carcinoma patients: correlation with radiation therapy-induced outcome. BMC Cancer 15:856.

Ghadjar P, Hayoz S, Bernhard J, Zwahlen DR, Hölscher T, Gut P, Guckenberger M, Hildebrandt G, Müller AC, Plasswilm L, Papachristofilou A, Stalder L, Biaggi-Rudolf C, Sumila M, Kranzbühler H, Najafi Y, Ost P, Azinwi NC, Reuter C, Bodis S, Kaouthar K, Wust P, Thalmann GN, Aebersold DM. (2015) Acute Toxicity and Quality of Life After Dose-Intensified Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: First Results of the Randomized Trial SAKK 09/10. J Clin Oncol 33(35):4158-66.

Kroeber J, Wenger B, Schwegler M, Daniel C, Schmidt M, Djuzenova CS, Polat B, Flentje M, Fietkau R, Distel LV. (2015) Distinct increased outliers among 136 rectal cancer patients assessed by ?H2AX. Radiat Oncol 10:36.

Kuger S, Flentje M, Djuzenova CS. (2015) Simultaneous perturbation of the MAPK and the PI3K/mTOR pathways does not lead to increased radiosensitization. Radiat Oncol 10:214.

Lewitzki V, Andratschke N, Kuhnt T, Hildebrandt G. (2015) Radiation myelitis after hypofractionated radiotherapy with concomitant gefitinib. Radiat Oncol 10:29.

Li M, Winkler B, Pabst T, Bley T, Köstler H, Neubauer H. (2015) Fast MR Imaging of the Paediatric Abdomen with CAIPIRINHA-Accelerated T1w 3D FLASH and with High-Resolution T2w HASTE: A Study on Image Quality. Gastroenterol Res Pract 2015:693654.

Peulen H, Belderbos J, Guckenberger M, Hope A, Grills I, van Herk M, Sonke JJ. (2015) Target delineation variability and corresponding margins of peripheral early stage NSCLC treated with stereotactic body radiotherapy. Radiother Oncol 114(3):361-6.

Schanne DH, Nestle U, Allgäuer M, Andratschke N, Appold S, Dieckmann U, Ernst I, Ganswindt U, Grosu AL, Holy R, Molls M, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Guckenberger M. (2015) Stereotactic body radiotherapy for centrally located stage I NSCLC: a multicenter analysis. Strahlenther Onkol 191(2):125-32.

Thibault I, Chang EL, Sheehan J, Ahluwalia MS, Guckenberger M, Sohn MJ, Ryu S, Foote M, Lo SS, Muacevic A, Soltys SG, Chao S, Gerszten P, Lis E, Yu E, Bilsky M, Fisher C, Schiff D, Fehlings MG, Ma L, Chang S, Chow E, Parelukar WR, Vogelbaum MA, Sahgal A. (2015) Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the SPIne response assessment in Neuro-Oncology (SPINO) group. Lancet Oncol 16(16):e595-603.

Thomas L, Lapa C, Bundschuh RA, Polat B, Sonke JJ, Guckenberger M. (2015) Tumour delineation in oesophageal cancer - A prospective study of delineation in PET and CT with and without endoscopically placed clip markers. Radiother Oncol 116(2):269-75.

Vaegler S, Stsepankou D, Hesser J, Sauer O. (2015) Incorporation of local dependent reliability information into the Prior Image Constrained Compressed Sensing (PICCS) reconstruction algorithm. Z Med Phys 25(4):375-90.

Völker M, Ehses P, Weick S, Breuer FA, Blaimer M, Hintze C, Biederer J, Jakob PM. (2015) Free breathing 1H MRI of the human lung with an improved radial turbo spin-echo. MAGMA 28(3):227-38.

Wohlleben G, Scherzad A, Güttler A, Vordermark D, Kuger S, Flentje M, Polat B. (2015) Influence of hypoxia and irradiation on osteopontin expression in head and neck cancer and glioblastoma cell lines. Radiat Oncol 10:167.

Publikationen 2014

Buder K, Müller PA, Beckmann G, Ugurel S, Bröcker EB, Becker JC. (2014) Denileukin diftitox plus total skin electron beam radiation in patients with treatment-refractory cutaneous T-cell Lymphoma (mycosis fungoides): report of four cases. Acta Derm Venereol 94(1):94-6.

Groh CM, Hubbard ME, Jones PF, Loadman PM, Periasamy N, Sleeman BD, Smye SW, Twelves CJ, Phillips RM. (2014) Mathematical and computational models of drug transport in tumours. J R Soc Interface 11(94):20131173.

Guckenberger M, Andratschke N, Alheit H, Holy R, Moustakis C, Nestle U, Sauer O, Deutschen Gesellschaft für Radioonkologie (DEGRO). (2014) Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer. Strahlenther Onkol 190(1):26-33.

Guckenberger M, Lawrenz I, Flentje M. (2014) Moderately hypofractionated radiotherapy for localized prostate cancer: long-term outcome using IMRT and volumetric IGRT. Strahlenther Onkol 190(1):48-53.

Guckenberger M, Mantel F, Gerszten PC, Flickinger JC, Sahgal A, Létourneau D, Grills IS, Jawad M, Fahim DK, Shin JH, Winey B, Sheehan J, Kersh R. (2014) Safety and efficacy of stereotactic body radiotherapy as primary treatment for vertebral metastases: a multi-institutional analysis. Radiat Oncol 9:226.

Holubyev K, Gainey M, Bratengeier K, Polat B, Flentje M. (2014) Generation of prostate IMAT plans adaptable to the inter-fractional changes of patient geometry. Phys Med Biol 59(8):1947-62.

Kestin L, Grills I, Guckenberger M, Belderbos J, Hope AJ, Werner-Wasik M, Sonke JJ, Bissonnette JP, Xiao Y, Yan D, Elekta Lung Research Group. (2014) Dose-response relationship with clinical outcome for lung stereotactic body radiotherapy (SBRT) delivered via online image guidance. Radiother Oncol 110(3):499-504.

Klement RJ, Allgäuer M, Appold S, Dieckmann K, Ernst I, Ganswindt U, Holy R, Nestle U, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Andratschke N, Guckenberger M. (2014) Support vector machine-based prediction of local tumor control after stereotactic body radiation therapy for early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 88(3):732-8.

Kocher M, Wittig A, Piroth MD, Treuer H, Seegenschmiedt H, Ruge M, Grosu AL, Guckenberger M. (2014) Stereotactic radiosurgery for treatment of brain metastases. A report of the DEGRO Working Group on Stereotactic Radiotherapy. Strahlenther Onkol 190(6):521-32.

Mantel F, Glatz S, Toussaint A, Flentje M, Guckenberger M. (2014) Long-term safety and efficacy of fractionated stereotactic body radiation therapy for spinal metastases. Strahlenther Onkol 190(12):1141-8.

Memmel S, Sukhorukov VL, Höring M, Westerling K, Fiedler V, Katzer A, Krohne G, Flentje M, Djuzenova CS. (2014) Cell surface area and membrane folding in glioblastoma cell lines differing in PTEN and p53 status. PLoS ONE 9(1):e87052.

Müller K, Schlamann A, Guckenberger M, Warmuth-Metz M, Glück A, Pietschmann S, Wawer A, Kortmann RD, Kramm C, von Bueren AO. (2014) Craniospinal irradiation with concurrent temozolomide for primary metastatic pediatric high-grade or diffuse intrinsic pontine gliomas. A first report from the GPOH-HIT-HGG Study Group. Strahlenther Onkol 190(4):377-81.

Serpa M, Baier K, Cremers F, Guckenberger M, Meyer J. (2014) Suitability of markerless EPID tracking for tumor position verification in gated radiotherapy. Med Phys 41(3):031702.

Sweeney R, Polat B, Samnick S, Reiners C, Flentje M, Verburg FA. (2014)    O-(2-[(18)F]fluoroethyl)-L-tyrosine uptake is an independent prognostic determinant in patients with glioma referred for radiation therapy. Ann Nucl Med 28(2):154-62.

Vaegler S, Bratengeier K, Beckmann G, Flentje M. (2014) Conformal breast irradiation with the arm of the affected side parallel to the body. Strahlenther Onkol 190(1):100-5.

van Oorschot B, Assenbrunner B, Schuler M, Beckmann G, Flentje M. (2014) Survival and prognostic factors after moderately hypofractionated palliative thoracic radiotherapy for non-small cell lung cancer. Strahlenther Onkol 190(3):270-5.

Wiegering A, Isbert C, Dietz UA, Kunzmann V, Ackermann S, Kerscher A, Maeder U, Flentje M, Schlegel N, Reibetanz J, Germer CT, Klein I. (2014) Multimodal therapy in treatment of rectal cancer is associated with improved survival and reduced local recurrence - a retrospective analysis over two decades. BMC Cancer 14:816.

Publikationen 2013

Djuzenova CS, Elsner I, Katzer A, Worschech E, Distel LV, Flentje M, Polat B. (2013) Radiosensitivity in breast cancer assessed by the histone ?-H2AX and 53BP1 foci. Radiat Oncol 8:98.

Gerszten PC, Sahgal A, Sheehan JP, Kersh R, Chen S, Flickinger JC, Quader M, Fahim D, Grills I, Shin JH, Winey B, Oh K, Sweeney RA, Guckenberger M. (2013) A multi-national report on methods for institutional credentialing for spine radiosurgery. Radiat Oncol 8:158.

Guckenberger M, Allgäuer M, Appold S, Dieckmann K, Ernst I, Ganswindt U, Holy R, Nestle U, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Andratschke N. (2013) Safety and efficacy of stereotactic body radiotherapy for stage 1 non-small-cell lung cancer in routine clinical practice: a patterns-of-care and outcome analysis. J Thorac Oncol 8(8):1050-8.

Guckenberger M, Klement RJ, Allgäuer M, Appold S, Dieckmann K, Ernst I, Ganswindt U, Holy R, Nestle U, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Andratschke N, Flentje M. (2013) Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer. Radiother Oncol 109(1):13-20.

Guckenberger M, Klement RJ, Kestin LL, Hope AJ, Belderbos J, Werner-Wasik M, Yan D, Sonke JJ, Bissonnette JP, Xiao Y, Grills IS. (2013) Lack of a dose-effect relationship for pulmonary function changes after stereotactic body radiation therapy for early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 85(4):1074-81.

Guckenberger M, Saur G, Wehner D, Thalheimer A, Kim M, Germer CT, Flentje M. (2013) Long-term quality-of-life after neoadjuvant short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer. Radiother Oncol 108(2):326-30.

Hahne JC, Meyer SR, Kranke P, Dietl J, Guckenberger M, Polat B, Hönig A. (2013) Studies on the role of osteopontin-1 in endometrial cancer cell lines. Strahlenther Onkol 189(12):1040-8.

Hartmann S, Günther N, Biehl M, Katzer A, Kuger S, Worschech E, Sukhorukov VL, Krohne G, Zimmermann H, Flentje M, Djuzenova CS. (2013) Hsp90 inhibition by NVP-AUY922 and NVP-BEP800 decreases migration and invasion of irradiated normoxic and hypoxic tumor cell lines. Cancer Lett 331(2):200-10.

Holubyev K, Bratengeier K, Gainey M, Polat B, Flentje M. (2013) Towards automated on-line adaptation of 2-Step IMRT plans: QUASIMODO phantom and prostate cancer cases. Radiat Oncol 8:263.

Kuger S, Graus D, Brendtke R, Günther N, Katzer A, Lutyj P, Polat B, Chatterjee M, Sukhorukov VL, Flentje M, Djuzenova CS. (2013) Radiosensitization of Glioblastoma Cell Lines by the Dual PI3K and mTOR Inhibitor NVP-BEZ235 Depends on Drug-Irradiation Schedule. Translational oncology 6(2):169-79.

Mantel F, Flentje M, Guckenberger M. (2013) Stereotactic body radiation therapy in the re-irradiation situation--a review. Radiat Oncol 8:7.

Müller K, Gnekow A, Falkenstein F, Scheiderbauer J, Zwiener I, Pietsch T, Warmuth-Metz M, Voges J, Nikkhah G, Flentje M, Combs SE, Vordermark D, Kocher M, Kortmann RD. (2013) Radiotherapy in pediatric pilocytic astrocytomas. A subgroup analysis within the prospective multicenter study HIT-LGG 1996 by the German Society of Pediatric Oncology and Hematology (GPOH). Strahlenther Onkol 189(8):647-55.

Polat B, Wohlleben G, Katzer A, Djuzenova CS, Technau A, Flentje M. (2013) Influence of osteopontin silencing on survival and migration of lung cancer cells.    Strahlenther Onkol 189(1):62-7.

Said HM, Hagemann C, Carta F, Katzer A, Polat B, Staab A, Scozzafava A, Anacker J, Vince GH, Flentje M, Supuran CT. (2013) Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including acetazolamide in human glioblastoma. Bioorg Med Chem 21(13):3949-57.

Sassowsky M, Gut P, Hölscher T, Hildebrandt G, Müller AC, Najafi Y, Kohler G, Kranzbühler H, Guckenberger M, Zwahlen DR, Azinwi NC, Plasswilm L, Takacs I, Reuter C, Sumila M, Manser P, Ost P, Böhmer D, Pilop C, Aebersold DM, Ghadjar P. (2013) Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10. Int J Radiat Oncol Biol Phys 87(3):534-41.

Seufferlein T, Porzner M, Becker T, Budach V, Ceyhan G, Esposito I, Fietkau R, Follmann M, Friess H, Galle P, Geißler M, Glanemann M, Gress T, Heinemann V, Hohenberger W, Hopt U, Izbicki J, Klar E, Kleeff J, Kopp I, Kullmann F, Langer T, Langrehr J, Lerch M, Löhr M, Lüttges J, Lutz M, Mayerle J, Michl P, Möller P, Molls M, Münter M, Nothacker M, Oettle H, Post S, Reinacher-Schick A, Röcken C, Roeb E, Saeger H, Schmid R, Schmiegel W, Schoenberg M, Siveke J, Stuschke M, Tannapfel A, Uhl W, Unverzagt S, van Oorschot B, Vashist Y, Werner J, Yekebas E, Guidelines Programme Oncology AWMF , German Cancer Society eV, German Cancer Aid. (2013) S3-guideline exocrine pancreatic cancer. Z Gastroenterol 51(12):1395-440.

Steinmann D, Vordermark D, Geinitz H, Aschoff R, Bayerl A, Gerstein J, Hipp M, van Oorschot B, Wypior HJ, Schäfer C. (2013) Proxy assessment of patients before and after radiotherapy for brain metastases. Results of a prospective study using the DEGRO brain module. Strahlenther Onkol 189(1):47-53.

Verburg FA, Sweeney R, Hänscheid H, Dießl S, Israel I, Löhr M, Vince GH, Flentje M, Reiners C, Samnick S. (2013) Patients with recurrent glioblastoma multiforme. Initial experience with p-[(131)I]iodo-L-phenylalanine and external beam radiation therapy. Nuklearmedizin 52(1):36-42.

Wilbert J, Baier K, Hermann C, Flentje M, Guckenberger M. (2013) Accuracy of real-time couch tracking during 3-dimensional conformal radiation therapy, intensity modulated radiation therapy, and volumetric modulated arc therapy for prostate cancer. Int J Radiat Oncol Biol Phys 85(1):237-42.

Yarahmadi M, Allahverdi M, Nedaie HA, Asnaashari K, Vaezzadeh SA, Sauer OA. (2013) Improvement of the penumbra for small radiosurgical fields using flattening filter free low megavoltage beams. Z Med Phys 23(4):291-9.

Publikationen 2012

Bratengeier K, Oechsner M, Gainey M. (2012) Methods for monitor-unit-preserving adaptation of intensity modulated arc therapy techniques to the daily target-A simple comparison. Med Phys 39(2):713-20.

Bratengeier K, Seubert B, Holubyev K, Schachner H. (2012) Considerations on IMRT for quasi-isotropic non-coplanar irradiation. Phys Med Biol 57(22):7303-15.

Djuzenova CS, Blassl C, Roloff K, Kuger S, Katzer A, Niewidok N, Günther N, Polat B, Sukhorukov VL, Flentje M. (2012) Hsp90 inhibitor NVP-AUY922 enhances radiation sensitivity of tumor cell lines under hypoxia. Cancer Biol Ther 13(6):425-34.

Grills IS, Hope AJ, Guckenberger M, Kestin LL, Werner-Wasik M, Yan D, Sonke JJ, Bissonnette JP, Wilbert J, Xiao Y, Belderbos J. (2012) A collaborative analysis of stereotactic lung radiotherapy outcomes for early-stage non-small-cell lung cancer using daily online cone-beam computed tomography image-guided radiotherapy.    J Thorac Oncol 7(9):1382-93.

Guckenberger M, Alexandrow N, Flentje M. (2012) Radiotherapy alone for stage I-III low grade follicular lymphoma: long-term outcome and comparison of extended field and total nodal irradiation. Radiat Oncol 7:103.

Guckenberger M, Hawkins M, Flentje M, Sweeney RA. (2012) Fractionated radiosurgery for painful spinal metastases: DOSIS - a phase II trial. BMC Cancer 12:530.

Guckenberger M, Kavanagh A, Partridge M. (2012) Combining advanced radiotherapy technologies to maximize safety and tumor control probability in stage III non-small cell lung cancer. Strahlenther Onkol 188(10):894-900.

Guckenberger M, Roesch J, Baier K, Sweeney RA, Flentje M. (2012) Dosimetric consequences of translational and rotational errors in frame-less image-guided radiosurgery. Radiat Oncol 7:63.

Guckenberger M, Saur G, Wehner D, Sweeney RA, Thalheimer A, Germer CT, Flentje M. (2012) Comparison of preoperative short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer. Strahlenther Onkol 188(7):551-7.

Hänscheid H, Sweeney RA, Flentje M, Buck AK, Löhr M, Samnick S, Kreissl M, Verburg FA. (2012) PET SUV correlates with radionuclide uptake in peptide receptor therapy in meningioma. Eur J Nucl Med Mol Imaging 39(8):1284-8.

Hardcastle N, Tomé WA, Cannon DM, Brouwer CL, Wittendorp PW, Dogan N, Guckenberger M, Allaire S, Mallya Y, Kumar P, Oechsner M, Richter A, Song S, Myers M, Polat B, Bzdusek K. (2012) A multi-institution evaluation of deformable image registration algorithms for automatic organ delineation in adaptive head and neck radiotherapy. Radiat Oncol 7:90.

Hintzsche H, Polat B, Schewe V, Djuzenova CS, Pfreundner L, Flentje M, Stopper H. (2012) Micronucleus formation kinetics in buccal mucosa cells of head and neck cancer patients undergoing radiotherapy. Toxicol Lett 212(1):33-7.

Huang K, Dahele M, Senan S, Guckenberger M, Rodrigues GB, Ward A, Boldt RG, Palma DA. (2012) Radiographic changes after lung stereotactic ablative radiotherapy (SABR)--can we distinguish recurrence from fibrosis? A systematic review of the literature. Radiother Oncol 102(3):335-42.

Kreissl MC, Hänscheid H, Löhr M, Verburg FA, Schiller M, Lassmann M, Reiners C, Samnick SS, Buck AK, Flentje M, Sweeney RA. (2012) Combination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma. Radiat Oncol 7:99.

Menten MJ, Guckenberger M, Herrmann C, Krauß A, Nill S, Oelfke U, Wilbert J. (2012) Comparison of a multileaf collimator tracking system and a robotic treatment couch tracking system for organ motion compensation during radiotherapy. Med Phys 39(11):7032-41.

Neuhaus W, Burek M, Djuzenova CS, Thal SC, Koepsell H, Roewer N, Förster CY. (2012) Addition of NMDA-receptor antagonist MK801 during oxygen/glucose deprivation moderately attenuates the upregulation of glucose uptake after subsequent reoxygenation in brain endothelial cells. Neurosci Lett 506(1):44-9.

Niewidok N, Wack LJ, Schiessl S, Stingl L, Katzer A, Polat B, Sukhorukov VL, Flentje M, Djuzenova CS. (2012) Hsp90 Inhibitors NVP-AUY922 and NVP-BEP800 May Exert a Significant Radiosensitization on Tumor Cells along with a Cell Type-Specific Cytotoxicity. Translational oncology 5(5):356-69.

Ohri N, Werner-Wasik M, Grills IS, Belderbos J, Hope A, Yan D, Kestin LL, Guckenberger M, Sonke JJ, Bissonnette JP, Xiao Y. (2012) Modeling local control after hypofractionated stereotactic body radiation therapy for stage I non-small cell lung cancer: a report from the elekta collaborative lung research group.    Int J Radiat Oncol Biol Phys 84(3):e379-84.

Schmitt P, Jakob PM, Kotas M, Flentje M, Haase A, Griswold MA. (2012) T-one insensitive steady state imaging: a framework for purely T2-weighted TrueFISP. Magn Reson Med 68(2):409-20.

Steinmann D, Paelecke-Habermann Y, Geinitz H, Aschoff R, Bayerl A, Bölling T, Bosch E, Bruns F, Eichenseder-Seiss U, Gerstein J, Gharbi N, Hagg J, Hipp M, Kleff I, Müller A, Schäfer C, Schleicher U, Sehlen S, Theodorou M, Wypior HJ, Zehentmayr F, van Oorschot B, Vordermark D. (2012) Prospective evaluation of quality of life effects in patients undergoing palliative radiotherapy for brain metastases. BMC Cancer 12:283.

Stingl L, Niewidok N, Müller N, Selle M, Djuzenova CS, Flentje M. (2012) Radiosensitizing effect of the novel Hsp90 inhibitor NVP-AUY922 in human tumour cell lines silenced for Hsp90?. Strahlenther Onkol 188(6):507-15.

Sweeney RA, Seubert B, Stark S, Homann V, Müller G, Flentje M, Guckenberger M. (2012) Accuracy and inter-observer variability of 3D versus 4D cone-beam CT based image-guidance in SBRT for lung tumors. Radiat Oncol 7:81.

van Oorschot B, Schuler M, Simon A, Flentje M. (2012) Advance directives: prevalence and attitudes of cancer patients receiving radiotherapy. Support Care Cancer 20(11):2729-36.

Kontakt, Öffnungszeiten, Sprechzeiten

Öffnungszeiten:

Terminvereinbarung allgemein:
Montag bis Donnerstag 07:30 Uhr bis 17:00 Uhr
Freitag 07:30 Uhr bis 15:00 Uhr

Terminvereinbarung privat:
Montag bis Donnerstag 08:00 Uhr bis 17:00 Uhr
Freitag 08:00 Uhr bis 15:00 Uhr

Telefon:

Terminvereinbarung allgemein:
+49 931 201-28894

Sekretariat und Terminvereinbarung privat:
Sabrina Pabst
+49 931 201-28891

Direktor:
Prof. Dr. Michael Flentje
+49 931 201-28890

E-Mail:
Sekretariat:
Pabst_S@ ukw.de

Prof. Dr. Michael Flentje
flentje_m@ ukw.de

Fax:
+49 931 201-28396


Anschrift:

Klinik und Poliklinik für Strahlentherapie des Universitätsklinikums | Kopfkliniken | Josef-Schneider-Str. 11 | Haus B2 | 97080 Würzburg | Deutschland